[Survival of patients with lung cancer in combined treatment using hyperglycemia].
The paper is concerned with the results of a randomized study of combined therapy of lung cancer patients including large field radiotherapy (total irradiation of 20 Gy, daily fractionation of 4 Gy) and induced hyperglycemia (22-23 mmol/l). The use of new variants of combined therapy was shown to increase significantly the survival of patients, however therapeutic efficacy was different depending on the time of hyperglycemia: whether it was used before radiotherapy sessions or after their discontinuation.
Zharkov
V V
VV
Demidchik
Iu E
IuE
Khodina
T V
TV
D000328:Adult; D001786:Blood Glucose; D003131:Combined Modality Therapy; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D007263:Infusions, Parenteral; D008175:Lung Neoplasms / Q000401:mortality* / Q000532:radiotherapy / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D013997:Time Factors
D001786:Blood Glucose; D005947:Glucose
Vyzhivaemost' bol'nykh rakom legkogo pri kombinirovannom lechenii s ispol'zovaniem giperglikemii.